Qubiotech develops and markets computer-aided diagnosis (CAD) software for medical image quantification. Our first product, NeuroCloud, offers automatic PET/MR image fusion, as well as PET image quantification, to nuclear medicine physicians, enabling more accurate and earlier diagnosis of neurological diseases such as epilepsy, Parkinson’s and different dementias, such as Alzheimer’s disease. quantitative information is given as statistical maps calculated by comparing the analysed patient with a database of healthy subjects. The software can be used online without distribution or installation, using modern cloud computing technology. Qubiotech’s main goal is to transform advanced research developments into routine clinical tools, improving both the productivity of healthcare systems and patient wellbeing.
Business areas:
Hospitals. Diagnostic Imaging Centres.
Business lines:
E-health.
Computer-aided diagnosis (CAD).
Cloud computing.